RHI Magnesita N.V. - RHIM.L

RHIM.L Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
RHIM.L	0.4	2.1	8.1	1.6	-4.2	2.8	-3.2	-4.3	6.5	6.5
S&P 500	1.0	0.6	1.1	2.4	8.9	23.6	36.4	80.6	195.1	33856.2

Compare RHIM.L with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	RHIM.L
name	RHI Magnesita N.V.
price	3460
changes percentage	0.4354
change	15
day low	3360
day high	3505
year high	3827.49
year low	3010
market cap	1632978140
price avg 50	3195.8
price avg 200	3365.175
exchange	LSE
volume	1188
avg volume	16809
open	3360
previous close	3445
eps	3.23
pe	10.71
earnings announcement	2025-02-27T11:00:00.000+0000
shares outstanding	47195900
timestamp	2025-01-21 11:36:59

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 73.3%

Overall Quarterly Financial Health: 33.3%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
revenue	3571800000	3317200000	7.68
gross profit	857400000	763400000	12.31
gross profit ratio	0.24	0.23	4.31
research and development expenses	46000000	36800000	25.00
operating expenses	550600000	418600000	31.53
interest income	19700000	8300000	137.35
interest expense	96500000	62800000	53.66
ebitda	507300000	477800000	6.17
ebitdaratio	0.14	0.14	-1.60
operating income	306800000	343600000	-10.71
operating income ratio	0.09	0.1	-17.07
net income	164600000	155700000	5.72
net income ratio	0.05	0.05	-1.82
eps	3.42	3.31	3.32

Overall Score of Annual Income Statement

0.75 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 3,572 million in 2023 from 3,317 million in 2022 representing a change of 7.68%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 857 million in 2023 from 763 million in 2022 representing a change of 12.31%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 46 million in 2023 from 37 million in 2022 representing a change of 25.0%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 507 million in 2023 from 478 million in 2022 representing a change of 6.17%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Net Income: Net income increased to 165 million in 2023 from 156 million in 2022 representing a change of 5.72%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 3.42 in 2023 from 3.42 in 2022 representing a change of 3.32%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Operating Expenses: Operating Expenses increased to 551 million in 2023 from 419 million in 2022 representing a change of 31.53%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  Operating Income: Operating income decreased to 307 million in 2023 from 344 million in 2022 representing a change of -10.71%. The decrease in operating income indicates worse operational performance and decreased profitability.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0000000000
revenue	864100000	864100000	0.00
gross profit	208000000	208000000	0.00
gross profit ratio	0.24	0.24	0.00
research and development expenses	11500000	11500000	0.00
operating expenses	136050000	122050000	11.47
interest income	14600000	14600000	0.00
interest expense	0	0	NaN
ebitda	108800000	108800000	0.00
ebitdaratio	0.13	0.13	0.00
operating income	71950000	65599999	9.68
operating income ratio	0.08	0.08	9.68
net income	50800000	50800000	0.00
net income ratio	0.06	0.06	0.00
eps	1.05	1.05	0.00

Overall Score of Quarterly Income Statement

0.5 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Operating Expenses: Operating Expenses increased to 136 million in 2024Q2 from 122 million in 2024Q1 representing a change of 11.47%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

• 📈 Positive Indicators

  Operating Income: Operating income increased to 72 million in 2024Q2 from 66 million in 2024Q1 representing a change of 9.68%. The increase in operating income indicates better operational performance and increased profitability.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
total assets	4849600000	4074900000	19.01
total liabilities	3486100000	3026300000	15.19
total equity	1363500000	1048600000	30.03
cash and cash equivalents	693600000	495500000	39.98
short term investments	11300000	-42400000	126.65
long term investments	46000000	60600000	-24.09
total current assets	2442200000	2188700000	11.58
total non current assets	2407400000	1886200000	27.63
total current liabilities	1095100000	1113900000	-1.69
total non current liabilities	2391000000	1912400000	25.03
common stock	49500000	49500000	0.00
retained earnings	1160100000	620200000	87.05
total debt	2001200000	1674900000	19.48

Overall Score of Annual Balance Sheet

0.78 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 4,850 million in 2023 from 4,075 million in 2022 representing a change of 19.01%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 1,364 million in 2023 from 1,049 million in 2022 representing a change of 30.03%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 694 million in 2023 from 496 million in 2022 representing a change of 39.98%. This indicates an increase in available liquid assets.

  Short Term Investments: Short Term Investments increased to 11 million in 2023 from -42 million in 2022 representing a change of 126.65%. This indicates an increase in short-term investment holdings.

  Total Current Assets: Total Current Assets increased to 2,442 million in 2023 from 2,189 million in 2022 representing a change of 11.58%. This indicates a better liquidity position.

  Total Current Liabilities: Total Current Liabilities decreased to 1,095 million in 2023 from 1,114 million in 2022 representing a change of -1.69%. This indicates a lower short-term debt burden.

  Retained Earnings: Retained Earnings increased to 1,160 million in 2023 from 620 million in 2022 representing a change of 87.05%. This indicates an accumulated profits.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 3,486 million in 2023 from 3,026 million in 2022 representing a change of 15.19%. This indicates an increase in overall liabilities.

  Total Debt: Total Debt increased to 2,001 million in 2023 from 1,675 million in 2022 representing a change of 19.48%. This indicates an increase in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0000000000
total assets	4652400000	4652400000	0.0
total liabilities	3250800001	3250800000	0.0
total equity	1401599999	1401599999	0.0
cash and cash equivalents	604800000	604800000	0.0
short term investments	2300000	2300000	0.0
long term investments	67900000	67900000	0.0
total current assets	2258000000	2258000000	0.0
total non current assets	2394400000	2394400000	0.0
total current liabilities	1183300000	1183300000	0.0
total non current liabilities	2067500001	2067500000	0.0
common stock	49500000	49500000	0.0
retained earnings	1203400000	1203400000	0.0
total debt	1878200000	1878200000	0.0

Overall Score of Quarterly Balance Sheet

0.0 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 3,251 million in 2024Q2 from 3,251 million in 2024Q1 representing a change of 0.0%. This indicates an increase in overall liabilities.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
net change in cash	182800000	-60100000	404.16
operating cash flow	499700000	233800000	113.73
free cash flow	320200000	77100000	315.30
capital expenditure	-179500000	-156700000	-14.55
depreciation and amortization	177500000	144500000	22.84
deferred income tax	0	-4600000	100.00
stock based compensation	0	4600000	-100.00
accounts payables	0	12500000	-100.00
inventory	182700000	-30000000	709.00
acquisitions net	-311400000	-54500000	-471.38
investments in property plant and equipment	-179500000	-156700000	-14.55
net cash used for investing activites	-481700000	-199700000	-141.21
debt repayment	259500000	54200000	378.78
common stock issued	100200000	0	NaN
common stock repurchased	0	0	NaN
dividends paid	-77700000	-70500000	-10.21
net cash used provided by financing activities	178000000	-83900000	312.16
cash at end of period	703500000	520700000	35.11
accounts receivables	1700000	-12500000	113.60
cash at beginning of period	520700000	580800000	-10.35

Overall Score of Annual Cashflow Statement

0.67 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 183 million in 2023 from -60 million in 2022 representing a change of 404.16%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 500 million in 2023 from 234 million in 2022 representing a change of 113.73%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 320 million in 2023 from 77 million in 2022 representing a change of 315.3%. This indicates an increase in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure decreased to -180 million in 2023 from -157 million in 2022 representing a change of -14.55%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.

  Stock-Based Compensation: Stock-Based Compensation decreased to 0 million in 2023 from 5 million in 2022 representing a change of -100.0%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.

  Accounts Payables: The absolute value of Accounts Payables decreased to 0 million in 2023 from 12 million in 2022 representing a change of -100.0%. This indicates that the company has reduced its outstanding obligations to its suppliers.

• 📉 Negative Indicators

  Deferred Income Tax: Deferred Income Tax increased to 0 million in 2023 from -5 million in 2022 representing a change of 100.0%. This indicates that the company's tax liability for future periods has increased.

  Accounts Receivables: Accounts Receivables increased to 2 in 2023 from -12 million in 2022 representing a change of 113.6%. This suggests that the company is less capable of collecting payments from its customers.

  Dividends Paid: Dividends Paid decreased to -78 million in 2023 from -70 million in 2022 representing a change of -10.21%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0000000000
operating cash flow	124550000	124550000	0.0
free cash flow	90650000	90650000	0.0
capital expenditure	-33900000	-33900000	0.0
depreciation and amortization	43200000	43200000	0.0
deferred income tax	0	0	NaN
stock based compensation	0	0	NaN
accounts receivables	31150000	31150000	0.0
accounts payables	0	0	NaN
inventory	750000	750000	0.0
acquisitions net	-20550000	-20550000	0.0
investments in property plant and equipment	-33900000	-33900000	0.0
net cash used for investing activites	-40250000	-40250000	0.0
debt repayment	0	0	NaN
common stock issued	0	0	NaN
common stock repurchased	0	0	NaN
dividends paid	-29500000	-29500000	0.0
net cash used provided by financing activities	-135650000	-135650000	0.0
net change in cash	-49350000	-49350000	0.0
cash at end of period	-49350000	-49350000	0.0
cash at beginning of period	0	0	NaN

Overall Score of Quarterly Cashflow Statement

0.5 out of 1

Detailed Analysis

Earnings Transcripts ⓘ

No earnings transcripts available.

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	74.21	70.58	5.15
net income per share	3.42	3.31	3.24
operating cash flow per share	10.38	4.97	108.72
free cash flow per share	6.65	1.64	305.57
cash per share	14.65	9.64	51.93
book value per share	28.33	22.31	26.98
tangible book value per share	11.52	15.58	-26.07
shareholders equity per share	24.97	21.3	17.21
interest debt per share	43.59	36.97	17.89
market cap	1918036595.23	1180661545.02	62.45
enterprise value	3225636595.23	2360061545.02	36.68
pe ratio	11.65	7.58	53.67
price to sales ratio	0.54	0.36	50.87
pocfratio	3.84	5.05	-23.99
pfcf ratio	5.99	15.31	-60.88
pb ratio	1.6	1.18	35.35
ptb ratio	1.6	1.18	35.35
ev to sales	0.9	0.71	26.93
enterprise value over ebitda	6.36	4.94	28.73
ev to operating cash flow	6.46	10.09	-36.05
ev to free cash flow	10.07	30.61	-67.09
earnings yield	0.09	0.13	-34.93
free cash flow yield	0.17	0.07	155.64
debt to equity	1.67	1.67	-0.45
debt to assets	0.41	0.41	0.40
net debt to ebitda	2.58	2.47	4.42
current ratio	2.23	1.96	13.50
interest coverage	3.18	5.47	-41.89
income quality	2.92	1.4	108.12
dividend yield	0.04	0.06	-32.16
payout ratio	0.47	0.45	4.25
sales general and administrative to revenue	0.1	0.09	14.82
research and ddevelopement to revenue	0.01	0.01	16.09
intangibles to total assets	0.17	0.08	115.05
capex to operating cash flow	0.36	0.67	-46.40
capex to revenue	0.05	0.05	6.38
capex to depreciation	1.01	1.08	-6.75
stock based compensation to revenue	0	0.0	-100.00
graham number	43.83	39.85	10.00
roic	0.06	0.07	-13.24
return on tangible assets	0.04	0.04	-1.66
graham net net	-39.14	-36.75	-6.50
working capital	1347100000	1074800000	25.33
tangible asset value	554500000	732500000	-24.30
net current asset value	-1043900000	-837600000	-24.63
invested capital	3250500000	2732000000	18.98
average receivables	489000000	422100000	15.85
average payables	502200000	577850000	-13.09
average inventory	1009700000	1000200000	0.95
days sales outstanding	55.29	48.07	15.02
days payables outstanding	66.95	72.39	-7.51
days of inventory on hand	132.2	148.11	-10.75
receivables turnover	6.6	7.59	-13.06
payables turnover	5.45	5.04	8.12
inventory turnover	2.76	2.46	12.04
roe	0.14	0.16	-11.92
capex per share	3.73	3.33	11.87

• ROE:

  Debt-to-Equity Ratio:

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 11.65 on 2023-12-31 from 7.58 on 2022-12-31, representing a change of 53.67%. Indicating an increase in the relative valuation of the company's stock.

  Current Ratio: Current Ratio increased to 2.23 on 2023-12-31 from 1.96 on 2022-12-31, representing a change of 13.50%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.

• Quarterly Financial Ratios

	2024-06-30 Q2	2024-03-31 Q1	Q/Q change %
RHIM.L
calendar year	2024	2024	NaN
revenue per share	17.86	17.86	0.00
net income per share	1.05	1.05	0.00
operating cash flow per share	2.57	2.57	0.00
free cash flow per share	1.87	1.87	0.00
cash per share	12.55	12.55	0.00
book value per share	28.97	28.97	-0.00
tangible book value per share	12.63	12.63	-0.00
shareholders equity per share	25.38	25.38	0.00
interest debt per share	38.82	38.82	0.00
market cap	1976070732.63	1952250564.44	1.22
enterprise value	3249470732.63	3225650564.44	0.74
pe ratio	9.72	9.61	1.22
price to sales ratio	2.29	2.26	1.22
pocfratio	15.87	15.67	1.22
pfcf ratio	21.8	21.54	1.22
pb ratio	1.61	1.59	1.22
ptb ratio	1.61	1.59	1.22
ev to sales	3.76	3.73	0.74
enterprise value over ebitda	29.87	29.65	0.74
ev to operating cash flow	26.09	25.9	0.74
ev to free cash flow	35.85	35.58	0.74
earnings yield	0.03	0.03	-1.21
free cash flow yield	0.05	0.05	-1.21
debt to equity	1.53	1.53	0.00
debt to assets	0.4	0.4	0.00
net debt to ebitda	11.7	11.7	0.00
current ratio	1.91	1.91	0.00
interest coverage	0	0	NaN
income quality	2.45	2.45	0.00
dividend yield	0.01	0.02	-1.21
payout ratio	0.58	0.58	0.00
sales general and administrative to revenue	0.1	0.1	0.00
research and ddevelopement to revenue	0.01	0.01	0.00
intangibles to total assets	0.17	0.17	0.00
capex to operating cash flow	0.27	0.27	0.00
capex to revenue	0.04	0.04	0.00
capex to depreciation	0.78	0.78	0.00
stock based compensation to revenue	0	0	NaN
graham number	24.49	24.49	0.00
roic	0.01	0.01	9.68
return on tangible assets	0.01	0.01	0.00
graham net net	-36.94	-36.94	-0.00
working capital	1074700000	1074700000	0.00
tangible asset value	611199999	611200000	-0.00
net current asset value	-992800001	-992800000	-0.00
invested capital	3186700000	3186700000	0.00
average receivables	477400000	509250000	-6.25
average payables	524600000	511250000	2.61
average inventory	996700000	989900000	0.69
days sales outstanding	49.72	49.72	0.00
days payables outstanding	71.96	71.96	0.00
days of inventory on hand	136.72	136.72	0.00
receivables turnover	1.81	1.81	0.00
payables turnover	1.25	1.25	0.00
inventory turnover	0.66	0.66	0.00
roe	0.04	0.04	0.00
capex per share	0.7	0.7	0.00

• Negative

  ROE: Return on Equity (ROE) decreased to 0.04 on 2024-06-30 Q2 from 0.04 on 2024-03-31 Q1, representing a change of 0.00%. Suggesting that the company has not been generating high returns for its shareholders.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 9.72 on 2024-06-30 Q2 from 9.61 on 2024-03-31 Q1, representing a change of 1.22%. Indicating an increase in the relative valuation of the company's stock.

• Neutral

  Current Ratio: Current Ratio decreased to 1.91 on 2024-06-30 Q2 from 1.91 on 2024-03-31 Q1, representing a change of 0.00%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

• Debt-to-Equity Ratio:

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Negative Sentiment: Discounted Cash Flow value is 1615.79 which is lower than current price 3460, indicates the company may be overvalued.